Results 21 to 30 of about 85,967 (221)

sIL-2R [PDF]

open access: yesSpringer Reference Medizin, 2019

semanticscholar   +2 more sources

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. [PDF]

open access: yesBritish Journal of Cancer, 1998
The aim of this study was to assess the prognostic role of soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease (HD) both in the achievement of complete remission (CR) and in predicting disease relapse.
S. Viviani   +9 more
semanticscholar   +3 more sources

Role of soluble interleukin-2 receptor (sIL-2R) as a predictor for severe dengue infection [PDF]

open access: yesScientific Reports
Annually, around half a million people with severe dengue require hospitalization, all over the globe, with around 12,500 (2.5%) succumbing to the illness.
Arkit Deep Singh   +6 more
doaj   +2 more sources

Prediction of long-term major adverse cardiac events after myocardial infarction: value of combination of inflammatory biomarkers and GRACE score [PDF]

open access: yesFrontiers in Cardiovascular Medicine
ObjectiveThis study aims to investigate the prognostic value of integrating inflammatory biomarkers with the established Global Registry of Acute Coronary Events (GRACE) risk score for predicting clinical outcomes in patients with myocardial infarction ...
Dan Tian   +9 more
doaj   +2 more sources

Relationship between levels of serum gastric inhibitory polypeptide (GIP), soluble interleukin-2 receptor (sIL-2R), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and disease condition and prognosis of patients with severe acute pancreatitis.

open access: yesAnnals of Palliative Medicine, 2021
BACKGROUND To explore the relationship between levels of serum gastric inhibitory polypeptide (GIP), soluble interleukin-2 receptor (sIL-2R), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and the disease condition and prognosis ...
Li Zeng   +6 more
semanticscholar   +1 more source

Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent Complex Regional Pain Syndrome? [PDF]

open access: yes, 2023
OBJECTIVE: A potentially useful biomarker for Complex Regional Pain Syndrome (CRPS) is the serum soluble interleukin-2 receptor (sIL-2R) level, which is a marker for T-cell activation.
Baart, Sara J.   +5 more
core   +2 more sources

sIL-2R: A Novel Diagnostic Biomarker for Primary Adrenal Lymphoma

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2022
Abstract Context Primary adrenal lymphoma (PAL) is difficult to distinguish from other adrenal masses. Soluble interleukin-2 receptor (sIL-2R) is a diagnostic biomarker for nodal non-Hodgkin lymphoma, whose association with PAL is unknown. Objective
Kai Yu   +12 more
openaire   +2 more sources

Factors influencing serum concentrations of soluble interleukin-2 receptor: a general adult population study

open access: yesAll Life, 2023
Introduction: Measuring soluble interleukin-2 receptor (sIL-2R) might be useful for diagnosis and monitoring of immune-mediated diseases. The study investigated factors associated with serum sIL-2R concentrations in adults.
Vanessa Alende-Castro   +6 more
doaj   +1 more source

Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma

open access: yesBMC Ophthalmology, 2022
Background Intraocular lymphoma (IOL) is a masquerade syndrome that mimics uveitis, making diagnosis difficult. The serum soluble interleukin-2 receptor (sIL-2R), which is cleaved by matrix metalloproteinase (MMP) -2 and MMP-9, has been recognized as a ...
Kayo Suzuki   +9 more
doaj   +1 more source

Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy

open access: yesScientific Reports, 2023
Patients with DLBCL achieving complete metabolic response (CMR) after initial treatment with R-CHOP generally have a favourable prognosis; however, there are no established prognostic biomarkers for relapse in these patients.
Yuko Shirouchi   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy